Cover Image

МІНІМАЛЬНА ЗАЛИШКОВА ХВОРОБА ПРИ ГОСТРІЙ ЛІМФОБЛАСТНІЙ ЛЕЙКЕМІЇ: МЕТОДИ ВИЯВЛЕННЯ ТА КІЛЬКІСНОГО ВИЗНАЧЕННЯ

Recently, the identification of minimal residual disease (MRD), also known as measurable residual disease, has seen significant advances driven by the evolving technological landscape in this field. Initially based on raw morphology, the field has since evolved to incorporate karyotyping, cytogeneti...

Full description

Saved in:
Bibliographic Details
Published in:Експериментальна онкологія
Date:2026
Volume:48
Issue:2
Pages:98-107
ISSN:2312-8852
Author Affiliations:
  • Sara Addakiri — Hassan II University of Medicine and Pharmacy, Casablanca, Morocco — ORCID: 0009-0008-5751-9846
  • Hanaa Bencharef — Hassan II University of Medicine and Pharmacy, Casablanca, Morocco — ORCID: 0000-0002-0086-0815
  • Asmaa Harrach — Hassan II University of Medicine and Pharmacy, Casablanca, Morocco — ORCID: 0000-0002-7524-0688
  • Samiha Jaddaoui — Hassan II University of Medicine and Pharmacy, Casablanca, Morocco
  • Khadija Ait-Ichou — IBN ROCHD Hospital Centre, Casablanca, Morocco
  • Bouchra Oukkache — Hassan II University of Medicine and Pharmacy, Casablanca, Morocco — ORCID: 0000-0003-2022-1938
Main Authors: Addakiri, Sara, Bencharef, Hanaa, Harrach, Asmaa, Jaddaoui, Samiha, Ait-Ichou, Khadija, Oukkache, Bouchra
Format: Article
Language:English
Published: PH Akademperiodyka 2026
Online Access:https://exp-oncology.com.ua/index.php/Exp/article/view/640
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Experimental Oncology
Download file: Pdf

Institution

Experimental Oncology
Description
Summary:Recently, the identification of minimal residual disease (MRD), also known as measurable residual disease, has seen significant advances driven by the evolving technological landscape in this field. Initially based on raw morphology, the field has since evolved to incorporate karyotyping, cytogenetics, flow cytometry, and other sensitive methods. This updated review discusses key technical considerations for successful MRD detection. We explore the correlation between the results obtained by flow cytometry and molecular genetic techniques.
ISSN:2312-8852
DOI:10.15407/exp-oncology.2026.02.098

Similar Items